☰

How effective will the use of monoclonal antibody-based approaches be within asthma & COPD drug development and future commercial pipelines?

Pharmaceuticals & Biotechnology Editor |

How effective will the use of monoclonal antibody-based approaches be within asthma & COPD drug development and future commercial pipelines?

RECOMMENDED

Steps for a successful merger and acquisition in pharma
2022-11-29

Why change management is necessary in the pharmaceutical industry
2022-11-23

Big pharma CEOs announce net zero action plan
2022-11-03

The impact of the energy crisis on pharma
2022-10-03

Upcoming Events

DigIT Pharma & Health 2024

September 10 - 12, 2024
Düsseldorf, Germany
Register Now | View Agenda | Learn More

Temperature Control and Logistics North America Summit

September 10 - 12, 2024
Falls Church, VA
Register Now | View Agenda | Learn More

Pharma Contract Manufacturing

08 - 10 April, 2025
Berlin
Register Now | View Agenda | Learn More

MORE EVENTS